Hong Kong's Securities and Futures Commission has conducted an inquiry into the shareholding structure of Modern Chinese Medicine Group (01643). The investigation revealed that as of March 30, 2026, twenty-five shareholders and their associates collectively held 652 million shares in the company, representing 90.6% of its issued share capital. Consequently, only 67.6747 million shares, or 9.4% of the issued capital, were held by other investors. The company's closing share price surged 316% from HK$0.51 on December 31, 2025, to HK$2.12 by March 30, 2026. On April 13, 2026, the share price closed at HK$2.94, reflecting a 476% increase compared to the HK$0.51 closing price on December 31, 2025.